About us

Our mission is to bring context to the world of biology and human health through the power of spatial phenotyping. Akoya’s single-cell imaging solutions phenotype cells with spatial context to visualize how they organize and interact to influence disease progression and treatment response.

About us

Our mission is to bring context to the world of biology and human health through the power of spatial phenotyping. Akoya’s single-cell imaging solutions phenotype cells with spatial context to visualize how they organize and interact to influence disease progression and treatment response.

Explore our history

Akoya Biosciences Acquires Phenoptics

Akoya Biosciences acquires the Phenoptics portfolio from PerkinElmer to establish a combined portfolio of complementary technologies.

PerkinElmer Acquires Caliper Life Sciences

The Phenoptics™ portfolio, based on MSI technology, becomes the industry standard for multiplexed tissue analysis in translational research.

Cambridge Research & Instrumentation (CRI)

CRI is co-founded by Peter Miller and Cliff Hoyt to commercialize revolutionary Multispectral Imaging (MSI) technology. CRI is acquired by Caliper Life Sciences in 2010 to accelerate MSI development for tissue biomarker analysis.

The Spatial Biology Company®

Combining the strengths of CODEX and Phenoptics to accelerate tissue biomarker development, from discovery to translation.

Akoya Biosciences is Founded

Akoya Biosciences was founded to commercialize the CODEX® technology, developed in the lab of Dr. Garry Nolan at Stanford University, to enable ultrahigh multiplexed analysis for biomarker discovery.

Explore our history

TODAY
The Spatial Biology Company®

Combining the strengths of CODEX and Phenoptics to accelerate tissue biomarker development, from discovery to translation.

2018
Akoya Biosciences Acquires Phenoptics

Akoya Biosciences acquires the Phenoptics portfolio from PerkinElmer to establish a combined portfolio of complementary technologies.

2015
Akoya Biosciences is Founded

Akoya Biosciences was founded to commercialize the CODEX® technology, developed in the lab of Dr. Garry Nolan at Stanford University, to enable ultrahigh multiplexed analysis for biomarker discovery.

2011
PerkinElmer Acquires Caliper Life Sciences

The Phenoptics™ portfolio, based on MSI technology, becomes the industry standard for multiplexed tissue analysis in translational research.

1985
Cambridge Research & Instrumentation (CRI)

CRI is co-founded by Peter Miller and Cliff Hoyt to commercialize revolutionary Multispectral Imaging (MSI) technology. CRI is acquired by Caliper Life Sciences in 2010 to accelerate MSI development for tissue biomarker analysis.

Brian McKelligon
CEO, Akoya Biosciences

leadership-Brian-McKelligon
Akoya is excited to bring unprecedented power, scale, and automation to histology and single-cell analysis through our multiplex immunofluorescence solutions. With both the Phenoptics and CODEX portfolios, we provide our customers with a full suite of end-to-end solutions for high parameter tissue analysis.
leadership-Brian-McKelligon

Brian McKelligon
CEO, Akoya Biosciences

Akoya is excited to bring unprecedented power, scale, and automation to histology and single-cell analysis through our multiplex immunofluorescence solutions. With both the Phenoptics and CODEX portfolios, we provide our customers with a full suite of end-to-end solutions for high parameter tissue analysis.